Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-013679
Filing Date
2025-05-19
Accepted
2025-05-19 17:45:58
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 form4-05192025_090554.html 4  
1 form4-05192025_090554.xml 4 18858
  Complete submission text file 0001415889-25-013679.txt   20430
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 25965298

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)